In addition, an increase in isoform 2 of malate dehydrogenase was observed in mtGR-expressing tumors in line with previous observations, demonstrating increased malate dehydrogenase-2 in hepatocellular carcinoma and proposing MDH-2 as a new cancer biomarker [25,26]. This evidence concerns the gene MDH2 and hepatocellular carcinoma.